financetom
Business
financetom
/
Business
/
US FDA places clinical hold on Intellia's two gene-editing treatment trials
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA places clinical hold on Intellia's two gene-editing treatment trials
Oct 29, 2025 2:26 PM

Oct 29 (Reuters) - Intellia Therapeutics ( NTLA ) said

on Wednesday that the U.S. Food and Drug Administration has

placed a clinical hold on its two late-stage trials testing an

experimental gene-editing therapy for a rare disease that can

damage the heart and nerves.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved